Franciscus M. H. de Groot

1.2k total citations
15 papers, 954 citations indexed

About

Franciscus M. H. de Groot is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Franciscus M. H. de Groot has authored 15 papers receiving a total of 954 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 8 papers in Oncology and 5 papers in Cancer Research. Recurrent topics in Franciscus M. H. de Groot's work include Peptidase Inhibition and Analysis (5 papers), Cancer therapeutics and mechanisms (3 papers) and Chemical Synthesis and Analysis (3 papers). Franciscus M. H. de Groot is often cited by papers focused on Peptidase Inhibition and Analysis (5 papers), Cancer therapeutics and mechanisms (3 papers) and Chemical Synthesis and Analysis (3 papers). Franciscus M. H. de Groot collaborates with scholars based in Netherlands, Italy and Finland. Franciscus M. H. de Groot's co-authors include Hans W. Scheeren, Patrick H. Beusker, Eric W. P. Damen, Guuske F. Busscher, Carsten Albrecht, A.C.W. de Bart, Jan H. Verheijen, Walter J. Loos, Peter de Bruijn and Gijs Verheijden and has published in prestigious journals such as Angewandte Chemie International Edition, The FASEB Journal and Journal of Medicinal Chemistry.

In The Last Decade

Franciscus M. H. de Groot

15 papers receiving 922 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Franciscus M. H. de Groot Netherlands	12	519	312	305	199	197	15	954
Patrick H. Beusker Netherlands	8	248 0.5×	322 1.0×	172 0.6×	148 0.7×	263 1.3×	23	652
Antony Godwin United Kingdom	14	820 1.6×	391 1.3×	575 1.9×	189 0.9×	539 2.7×	19	1.5k
Isabella C. Hume United Kingdom	9	319 0.6×	189 0.6×	168 0.6×	69 0.3×	147 0.7×	9	730
Arwin J. Brouwer Netherlands	24	980 1.9×	173 0.6×	1.0k 3.4×	221 1.1×	165 0.8×	46	1.6k
Gary R. Braslawsky United States	20	570 1.1×	372 1.2×	142 0.5×	58 0.3×	496 2.5×	34	1.2k
Dalton King United States	17	463 0.9×	314 1.0×	294 1.0×	44 0.2×	436 2.2×	26	1.0k
Karolyn A. Oetjen United States	13	686 1.3×	131 0.4×	283 0.9×	46 0.2×	135 0.7×	25	1.0k
Sandra J. Hofstead United States	14	728 1.4×	636 2.0×	417 1.4×	45 0.2×	659 3.3×	14	1.6k
Alberto Dal Corso Italy	18	637 1.2×	411 1.3×	316 1.0×	37 0.2×	378 1.9×	39	1.0k
Ahmad Safavy United States	15	383 0.7×	273 0.9×	117 0.4×	35 0.2×	259 1.3×	28	994

Countries citing papers authored by Franciscus M. H. de Groot

Since Specialization

Citations

This map shows the geographic impact of Franciscus M. H. de Groot's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Franciscus M. H. de Groot with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Franciscus M. H. de Groot more than expected).

Fields of papers citing papers by Franciscus M. H. de Groot

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Franciscus M. H. de Groot. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Franciscus M. H. de Groot. The network helps show where Franciscus M. H. de Groot may publish in the future.

Co-authorship network of co-authors of Franciscus M. H. de Groot

This figure shows the co-authorship network connecting the top 25 collaborators of Franciscus M. H. de Groot. A scholar is included among the top collaborators of Franciscus M. H. de Groot based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Franciscus M. H. de Groot. Franciscus M. H. de Groot is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Elgersma, Ronald C., Ruud G. E. Coumans, Wiro M. P. B. Menge, et al.. (2015). Design, Synthesis, and Evaluation of Linker-Duocarmycin Payloads: Toward Selection of HER2-Targeting Antibody–Drug Conjugate SYD985. Molecular Pharmaceutics. 12(6). 1813–1835. 163 indexed citations

Devy, Laetitia, Franciscus M. H. de Groot, Silvia Blacher, et al.. (2004). Plasmin‐activated doxorubicin prodrugs containing a spacer reduce tumor growth and angiogenesis without systemic toxicity. The FASEB Journal. 18(3). 565–567. 33 indexed citations

Groot, Franciscus M. H. de, et al.. (2003). “Cascade‐Release Dendrimers” Liberate All End Groups upon a Single Triggering Event in the Dendritic Core. Angewandte Chemie International Edition. 42(37). 4490–4494. 192 indexed citations

Groot, Franciscus M. H. de, et al.. (2003). “Cascade‐Release Dendrimers” Liberate All End Groups upon a Single Triggering Event in the Dendritic Core. Angewandte Chemie. 115(37). 4628–4632. 35 indexed citations

Damen, Eric W. P., et al.. (2002). Synthesis of novel paclitaxel prodrugs designed for bioreductive activation in hypoxic tumour tissue. Bioorganic & Medicinal Chemistry. 10(1). 71–77. 51 indexed citations

Groot, Franciscus M. H. de, Guuske F. Busscher, R. W. M. ABEN, & Hans W. Scheeren. (2002). Novel 20-Carbonate Linked Prodrugs of Camptothecin and 9-Aminocamptothecin Designed for Activation by Tumour-Associated Plasmin. Bioorganic & Medicinal Chemistry Letters. 12(17). 2371–2376. 40 indexed citations

Groot, Franciscus M. H. de, Henk J. Broxterman, G. I. Tesser, et al.. (2002). Design, synthesis, and biological evaluation of a dual tumor-specific motive containing integrin-targeted plasmin-cleavable doxorubicin prodrug.. PubMed. 1(11). 901–11. 73 indexed citations

Loos, Walter J., Jaap Verweij, Diederik F.S. Kehrer, et al.. (2002). Structural identification and biological activity of 7-methyl-10,11-ethylenedioxy-20(S)-camptothecin, a photodegradant of lurtotecan.. PubMed. 8(3). 856–62. 3 indexed citations

Groot, Franciscus M. H. de, Guuske F. Busscher, R. W. M. ABEN, & Hans W. Scheeren. (2002). Novel 20‐Carbonate Linked Prodrugs of Camptothecin and 9‐Aminocamptothecin Designed for Activation by Tumor‐Associated Plasmin. ChemInform. 33(51). 200–200. 1 indexed citations

10.

Groot, Franciscus M. H. de, Walter J. Loos, Guuske F. Busscher, et al.. (2001). Elongated Multiple Electronic Cascade and Cyclization Spacer Systems in Activatible Anticancer Prodrugs for Enhanced Drug Release. The Journal of Organic Chemistry. 66(26). 8815–8830. 92 indexed citations

11.

Groot, Franciscus M. H. de, Eric W. P. Damen, & Hans W. Scheeren. (2001). Anticancer Prodrugs for Application in Monotherapy Targeting Hypoxia, Tumor-Associated Enzymes, and Receptors. Current Medicinal Chemistry. 8(9). 1093–1122. 101 indexed citations

12.

Groot, Franciscus M. H. de, et al.. (2000). Synthesis and Biological Evaluation of 2‘-Carbamate-Linked and 2‘-Carbonate-Linked Prodrugs of Paclitaxel: Selective Activation by the Tumor-Associated Protease Plasmin. Journal of Medicinal Chemistry. 43(16). 3093–3102. 83 indexed citations

13.

Groot, Franciscus M. H. de, A.C.W. de Bart, Jan H. Verheijen, & Hans W. Scheeren. (1999). Synthesis and Biological Evaluation of Novel Prodrugs of Anthracyclines for Selective Activation by the Tumor-Associated Protease Plasmin. Journal of Medicinal Chemistry. 42(25). 5277–5283. 53 indexed citations

14.

Groot, Franciscus M. H. de, et al.. (1997). Towards Radiation‐Sensitive Quasi‐Biological Display. Angewandte Chemie International Edition in English. 36(9). 954–955. 2 indexed citations

15.

Groot, Franciscus M. H. de, et al.. (1996). Semisynthesis of Some 7-Deoxypaclitaxel Analogs from Taxine B. The Journal of Organic Chemistry. 61(20). 7092–7100. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact